Cargando…
PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data
PIK3CA mutations represent one of the most common genetic aberrations in breast cancer. They have been reported to be present in over one-third of cases, with enrichment in the luminal and in human epidermal growth factor receptor 2-positive subtypes. Substantial preclinical data on the oncogenic pr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054885/ https://www.ncbi.nlm.nih.gov/pubmed/25192370 http://dx.doi.org/10.1186/bcr3605 |